Keyue Ding
About
Keyue Ding is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology.
According to data from OpenAlex, Keyue Ding has authored 218 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Pulmonary and Respiratory Medicine, 88 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Keyue Ding's work include Lung Cancer Treatments and Mutations (65 papers), Lung Cancer Diagnosis and Treatment (31 papers) and Lung Cancer Research Studies (22 papers). Keyue Ding is often cited by papers focused on Lung Cancer Treatments and Mutations (65 papers), Lung Cancer Diagnosis and Treatment (31 papers) and Lung Cancer Research Studies (22 papers). Keyue Ding collaborates with scholars based in Canada, United States and China. Keyue Ding's co-authors include Frances A. Shepherd, Lesley Seymour, Ming‐Sound Tsao, Wendy R. Parulekar, Marlo Whitehead, Gary M. Clark, Iftikhar J. Kullo, Malcolm J. Moore, David Walde and Arié Figer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.
In The Last Decade
Keyue Ding
206 papers receiving 14.2k citations
Hit Papers
Peers
Keyue Ding
Hedy L. Kindler United States
Julian R. Molina United States
Heather A. Wakelee United States
Gabriella Fontanini Italy
Jacek Jassem Poland
Jin Seok Ahn South Korea
Shinichi Toyooka Japan
Vivek Subbiah United States
Keith M. Kerr United Kingdom
Camelia S. Sima United States
Citations per year, relative to Keyue Ding Keyue Ding (= 1×)
peers
Hedy L. Kindler
Countries citing papers authored by Keyue Ding
Since
Specialization
Citations
This map shows the geographic impact of Keyue Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyue Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyue Ding more than expected).
Fields of papers citing papers by Keyue Ding
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Keyue Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyue Ding. The network helps show where Keyue Ding may publish in the future.
Co-authorship network of co-authors of Keyue Ding
This figure shows the co-authorship network connecting the top 25 collaborators of Keyue Ding. A scholar is included among the top collaborators of Keyue Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyue Ding. Keyue Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Behroozian, Tara, Samantha Kennedy, Saverio Caini, et al.. (2023). Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials. Supportive Care in Cancer. 31(9). 524–524.
2.
Anagnostou, Valsamo, Cheryl Ho, Garth Nicholas, et al.. (2023). ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nature Medicine. 29(10). 2559–2569.
3.
Zhang, Chaohui, Yuxin Li, Beibei Yu, et al.. (2021). Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. Open Biology. 11(6). 210020–210020.
4.
Ye, Bo, et al.. (2021). DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines. SHILAP Revista de lepidopterología. Volume 8. 823–836.
5.
Song, Andrew, Keyue Ding, Iyad Alnahhas, et al.. (2021). Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG08.02) randomized clinical trial. Neuro-Oncology Advances. 3(1). vdab153–vdab153.
6.
Tremblay, Samuel, Frédéric Pouliot, Juanita Crook, et al.. (2021). Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer. The Journal of Urology. 206(5). 1166–1176.
7.
Zhang, Guiji, Li Liang, Wanfeng Zhang, et al.. (2020). DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. Oncogene. 39(16). 3229–3244.
8.
Brandes, Alba A., J. Gregory Cairncross, Keyue Ding, et al.. (2020). Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients. Journal of Neuro-Oncology. 149(1). 65–71.
9.
Hamilton, Robert J., Keyue Ding, Juanita Crook, et al.. (2020). The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy. European Urology. 79(4). 446–452.
10.
Toren, Paul, Keyue Ding, France‐Hélène Joncas, et al.. (2018). Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial. Clinical Cancer Research. 24(21). 5305–5312.
11.
Raman, Srinivas, Keyue Ding, Edward Chow, et al.. (2016). A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy. Radiotherapy and Oncology. 119(2). 208–212.
12.
Wong, Kit Man, Keyue Ding, Suzanne C. Li, et al.. (2016). A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 18(1). e41–e47.
13.
Péron, Julien, Pascal Roy, Keyue Ding, et al.. (2015). Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer. British Journal of Cancer. 112(6). 971–976.
14.
Foster, Nathan R., Lindsay A. Renfro, Steven E. Schild, et al.. (2015). Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(7). 1099–1106.
15.
Carbone, David P., Keyue Ding, Heinrich Röder, et al.. (2012). Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group BR.21 Trial. Journal of Thoracic Oncology. 7(11). 1653–1660.
16.
Wheatley‐Price, Paul, Aurélie Le Maître, Keyue Ding, et al.. (2010). The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy Trials. Journal of Thoracic Oncology. 5(5). 640–648.
17.
Perry, James, Chris J. O’Callaghan, Keyue Ding, et al.. (2010). A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme. Neuro-Oncology. 12. 38–38.
18.
Zhu, Chang‐Qi, Gilda da Cunha Santos, Keyue Ding, et al.. (2008). Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. Journal of Clinical Oncology. 26(26). 4268–4275.
19.
Früh, Martin, Estelle Rolland, Jean‐Pierre Pignon, et al.. (2008). Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(21). 3573–3581.
20.
Meyer, Ralph M., Mary Gospodarowicz, Joseph M. Connors, et al.. (2005). Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 23(21). 4634–4642.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hedy L. Kindler Breakdown of academic impact, for papers by Julian R. Molina Breakdown of academic impact, for papers by Heather A. Wakelee Breakdown of academic impact, for papers by Gabriella Fontanini Breakdown of academic impact, for papers by Jacek Jassem Breakdown of academic impact, for papers by Jin Seok Ahn Breakdown of academic impact, for papers by Shinichi Toyooka Breakdown of academic impact, for papers by Vivek Subbiah Breakdown of academic impact, for papers by Keith M. Kerr Breakdown of academic impact, for papers by Camelia S. Sima